Skip to main content
SpringerLink
Log in

Body Dysmorphic Disorder

Clinical Features and Drug Treatment

  • Practical Therapeutics
  • Published:
CNS Drugs Aims and scope Submit manuscript

Summary

Body dysmorphic disorder (BDD) is defined as a preoccupation with an imagined or minimal defect in appearance. Virtually any body part can be the focus of concern, although preoccupations with the hair, nose and skin are particularly common. Associated features include repetitive and often ritualistic behaviours, such as mirror checking and requests for reassurance, as well as ideas or delusions of reference. The degree of impairment associated with the disorder is variable, but most patients experience significant functional impairment as a result of their concerns.

While this often secret disorder has been described for more than a century and reported around the world, it has received little empirical investigation. Nonetheless, emerging data suggest that BDD is frequently a chronic disorder that usually begins during adolescence. Psychiatric hospitalisation and suicide attempts are common in patients with BDD. Disorders that are frequently comorbid include major depression, social phobia and obsessive-compulsive disorder. The prevalence of BDD among patients with other psychiatric disorders, such as atypical depression, obsessive-compulsive disorder and social phobia, appears to be relatively high.

The majority of patients with BDD seek often costly nonpsychiatric therapies, such as surgical or dermatological interventions. These approaches are usually unsuccessful. In contrast, preliminary data from noncomparative studies suggest that serotonin (5-hydroxytryptamine; 5-HT) reuptake inhibitors are often, and perhaps preferentially, effective in the treatment of BDD. Other preliminary data suggest that cognitive-behavioural strategies may also be useful. There are virtually no data on treatment-resistant BDD, but certain pharmacological approaches including augmentation, combination and switching strategies are sometimes effective.

Further investigation of all aspects of this understudied disorder is greatly needed. Aspects that require particular attention are the epidemiology, clinical features, relationship to other psychiatric disorders, biology and, ultimately, aetiology and treatment response.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Morselli E. Sulla dismorfofobia e sulla tafefobia. Bolletinno della R accademia di Genova 1891; 6: 110–9

    Google Scholar 

  2. Yamada M, Kobashi K, Shigemoto T, et al. On dysmorphophobia. Bull Yamaguchi Med School 1978; 25: 47–54

    Google Scholar 

  3. Vallat JN, Leger JM, Destruhaut J, et al. Dysmorphophobie: syndrome ou symptome? Ann Med Psychol (Paris) 1971; 2: 45–65

    CAS  Google Scholar 

  4. Bezoari M, Falcinelli D. Immagine del corpo e relazioni oggetuali: note sulla dismorfofobia. Rass Studi Psychiat 1977; 66: 489–510

    Google Scholar 

  5. von Zauner J. Das Krankheitsbild der Dysmorphophobie. Med et Hyg 1979; 37: 329–30

    Google Scholar 

  6. Korkina MB. The syndrome of dysmorphomania (dysmorphophobia) and the development of psychopathic personality. Zh Nevropatol Psikhiatr 1965; 65: 1212–7

    PubMed  CAS  Google Scholar 

  7. Phillips KA. Body dysmorphic disorder: the distress of imagined ugliness. Am J Psychiatry 1991; 148: 1138–49

    PubMed  CAS  Google Scholar 

  8. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed. Washington, DC: American Psychiatric Association, 1994

  9. World Health Organization. The 1CD-10 classification of mental and behavioural disorders — clinical descriptions and diagnostic guidelines. Geneva: World Health Organization, 1992

  10. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 3rd ed. revised. Washington DC: American Psychiatric Association, 1987

  11. Hay GG. Dysmorphophobia. Br J Psychiatry 1970; 116: 399–406

    Article  PubMed  CAS  Google Scholar 

  12. Zaidens SH. Dermatologic hypochondriasis: a form of schizophrenia. Psychosom Med 1950; 12: 250–3

    PubMed  CAS  Google Scholar 

  13. Ladee GA. Hypochondriacal syndromes. Amsterdam: Elsevier, 1966

    Google Scholar 

  14. Andreasen NC, Bardach J. Dysmorphophobia: symptom or disease? Am J Psychiatry 1977; 134: 673–6

    PubMed  CAS  Google Scholar 

  15. Fukuda O. Statistical analysis of dysmorphophobia in outpatient clinic. Jpn J Plast Reconstr Surg 1977; 20: 569–77

    Google Scholar 

  16. Phillips KA, Nierenberg AA, Fava M. Body dysmorphic disorder in atypical depression [abstract]. New research program and abstracts. American Psychiatric Association 147th Annual Meeting; 1994 May 21-26: Philadelphia. Philadelphia: American Psychiatric Association, 1994: 94

    Google Scholar 

  17. Hollander E, Cohen LJ, Simeon D. Body dysmorphic disorder. Psychiatr Ann 1993; 23: 359–64

    Google Scholar 

  18. Brawman-Mintzer O, Lydiard RB, Emmanuel NP, et al. Body dysmorphic disorder: a comorbidity study [abstract]. New research program and abstracts. American Psychiatric Association 147th Annual Meeting; 1994 May 21-26: Philadelphia. Philadelphia: American Psychiatric Association, 1994: 219

    Google Scholar 

  19. Phillips KA, McElroy SL, Keck Jr E, et al. Body dysmorphic disorder: 30 cases of imagined ugliness. Am J Psychiatry 1993; 150: 302–8

    PubMed  CAS  Google Scholar 

  20. Phillips KA, McElroy SL, Keck Jr E, et al. A comparison of delusional and nondelusional body dysmorphic disorder in 100 cases. Psychopharmacol Bull 1994; 30: 179–86

    PubMed  CAS  Google Scholar 

  21. Phillips KA, McElroy SL, Gunderson CG, et al. Body dysmorphic disorder: data on imagined ugliness [abstract]. Continuing medical education (CME) syllabus and proceedings. American Psychiatric Association 147th Annual Meeting; 1994 May 21-26: Philadelphia. Philadelphia: American Psychiatric Association, 1994: 299

    Google Scholar 

  22. McElroy SL, Phillips KA, Keck Jr E, et al. Body dysmorphic disorder: does it have a psychotic subtype? J Clin Psychiatry 1993; 54: 389–95

    PubMed  CAS  Google Scholar 

  23. Phillips KA, McElroy SL. Insight, overvalued ideation, and delusional thinking in body dysmorphic disorder: theoretical and treatment implications. J Nerv Ment Dis 1993; 181: 699–702

    Article  PubMed  CAS  Google Scholar 

  24. Spitzer RL, Williams JBW, Gibbon M, et al. The Structured Clinical Interview for DSM-III-R (SCID): I. History, rationale, and description. Arch Gen Psychiatry 1992; 49: 624–9

    Article  PubMed  CAS  Google Scholar 

  25. Williams JBW, Gibbon M, First MB, et al. The Structured Clinical Interview for DSM-III-R (SCID): II. Multisite test-retest reliability. Arch Gen Psychiatry 1992; 49: 630–6

    Article  PubMed  CAS  Google Scholar 

  26. Phillips KA, McElroy SL, Hudson JI, et al. Body dysmorphic disorders: an OCD-spectrum disorder, a form of affective spectrum disorder, or both? J Clin Psychiatry. In press

  27. Campanella FN, Zuccoli E. In tema di dismorfofobia. Neuropsichiatria 1968; 24: 475–86

    Google Scholar 

  28. Solyom L, DiNicola VF, Phil M, et al. Is there an obsessive psychosis? Aetiological and prognostic factors of an atypical form of obsessive-compulsive neurosis. Can J Psychiatry 1985; 30: 372–80

    PubMed  CAS  Google Scholar 

  29. Jenike MA. A case report of successful treatment of dysmorphophobia with tranylcypromine. Am J Psychiatry 1984; 141: 1463–4

    PubMed  CAS  Google Scholar 

  30. Hollander E, Liebowitz MR, Winchel R, et al. Treatment of body-dysmorphic disorder with serotonin reuptake blockers. Am J Psychiatry 1989; 146: 768–70

    PubMed  CAS  Google Scholar 

  31. Thomas CS. Dysmorphophobia: a question of definition. Br J Psychiatry 1984; 144: 513–6

    Article  PubMed  CAS  Google Scholar 

  32. Braddock LE. Dysmorphophobia in adolescence: a case report. Br J Psychiatry 1982; 140: 199–201

    Article  PubMed  CAS  Google Scholar 

  33. Cotterill JA. Dermatological non-disease: a common and potentially fatal disturbance of cutaneous body image. Br J Dermatol 1981; 104: 611–9

    Article  PubMed  CAS  Google Scholar 

  34. Vitiello B, de Leon J. Dysmorphophobia misdiagnosed as obsessive-compulsive disorder. Psychosomatics 1990; 31: 220–2

    Article  PubMed  CAS  Google Scholar 

  35. Marks I, Mishan J. Dysmorphophobic avoidance with disturbed bodily perception: a pilot study of exposure therapy. Br J Psychiatry 1988; 152: 674–8

    Article  PubMed  CAS  Google Scholar 

  36. Munro A, Chmara J. Monosymptomatic hypochondriacal psychosis: a diagnostic checklist based on 50 cases of the disorder. Can J Psychiatry 1982; 27: 374–6

    PubMed  CAS  Google Scholar 

  37. deLeon J, Bott A, Simpson GM. Dysmorphophobia: body dysmorphic disorder or delusional disorder, somatic subtype? Compr Psychiatry 1989; 30: 457–72

    Article  CAS  Google Scholar 

  38. Thomas CS. Dysmorphophobia or monosymptomatic hypochondriasis? [letter], Br J Psychiatry 1985; 146: 672

    Article  PubMed  CAS  Google Scholar 

  39. Brady KT, Austin L, Lydiard RB. Body dysmorphic disorder: the relationship to obsessive-compulsive disorder. J Nerv Ment Dis 1990; 178: 538–40

    PubMed  CAS  Google Scholar 

  40. Goodman WK, Price LH, Rasmussen SA, et al. The Yale Brown Obsessive Compulsive Scale (Y-BOCS): Part I. Development, use, and reliability. Arch Gen Psychiatry 1989; 46: 1006–16

    Article  PubMed  CAS  Google Scholar 

  41. Goodman WK, Price LH, Rasmussen SA, et al. The Yale Brown Obsessive Compulsive Scale (Y-BOCS): Part II. Validity. Arch Gen Psychiatry 1989; 46: 1012–6

    Article  PubMed  CAS  Google Scholar 

  42. Hollander E, Cohen L, Simeon D, et al. Fluvoxamine treatment of body dysmorphic disorder [letter]. J Clin Psychopharmacol 1994; 14: 75–7

    PubMed  CAS  Google Scholar 

  43. McDougle CJ, Goodman WK, Price LH, et al. Neuroleptic addition in fluvoxamine-refractory obsessive-compulsive disorder. Am J Psychiatry 1990; 147: 652–4

    PubMed  CAS  Google Scholar 

  44. Corbella T, Rossi L. La dysmorphophobie: ses aspects cliniques et nosographiques. Acta Neurol Bellg 1967; 67: 691–700

    CAS  Google Scholar 

  45. Carroll BJ. Response of major depression with psychosis and body dysmorphic disorder to ECT [letter]. Am J Psychiatry 1994; 151: 288–9

    PubMed  CAS  Google Scholar 

  46. Klages W, Hartwich P. Die Clowndysmorphophobie. Psychother Med Psychol 1982; 32: 183–7

    CAS  Google Scholar 

  47. Munjack DJ. The behavioral treatment of dysmorphobia. J Behav Ther Exp Psychiatry 1978; 9: 53–6

    Article  Google Scholar 

  48. Neziroglu FA, Yaryura-Tobias JA. Exposure, response prevention, and cognitive therapy in the treatment of body dysmorphic disorder. Behav Ther 1993; 24: 431–8

    Article  Google Scholar 

  49. Philoppopoulos GS. The analysis of a case of dsymorfophobia. Can J Psychiatry 1979; 24: 397–401

    Google Scholar 

  50. Bloch S, Glue P. Psychotherapy an dysmorphophobia: a case report. Br J Psychiatry 1988; 153: 271–4

    Article  Google Scholar 

  51. Olley PC. Psychiatric aspects of referral. BMJ 1974; 3: 248–9

    Article  PubMed  CAS  Google Scholar 

  52. von Haustein UF, Seikowski K. Dysmorphophobie-Bewahrungsfeld zwischen Dermatologen und Psychotherapeuten. Dermatol Monatsschr 1988; 174: 345–8

    PubMed  CAS  Google Scholar 

  53. Bezoari M, Falcinelli D. Immagine del corpo e relazioni oggetuali: note sulla dismorfofobia. Rass Studi Psychiat 1977; 66: 489–510

    Google Scholar 

  54. Phillips KA, McElroy SL, Lion JR. Body dysmorphic disorder in cosmetic surgery patients [letter]. J Plast Reconstr Surg 1992; 90: 333–4

    CAS  Google Scholar 

  55. Phillips KA, Hollander E. Body dysmorphic disorder: DSM-IV source book review. In: Frances A, editor. DSM-IV source book. Washington DC: American Psychiatric Press. In press

  56. Hollander E, Phillips KA. Body image and experience disorders: body dysmorphic and depersonalization disorders. In: Hollander E, editor. Obsessive compulsive-related disorders. Washington DC: American Psychiatric Press, 1992

    Google Scholar 

  57. Phillips KA, McElroy SL. Obsessive-compulsive disorder in relation to body dysmorphic disorder [letter]. Am J Psychiatry 1992; 149: 1284

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Outpatient Services and Body Dysmorphic Disorder Program, Butler Hospital, Butler Hospital, 345 Blackstone Blvd, Providence, Rhode Island, 02906, USA

    Katharine A. Phillips

  2. Brown University School of Medicine, Rhode Island, USA

    Katharine A. Phillips

Authors
  1. Katharine A. Phillips
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Phillips, K.A. Body Dysmorphic Disorder. CNS Drugs 3, 30–40 (1995). https://doi.org/10.2165/00023210-199503010-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00023210-199503010-00004

Keywords

Search

Navigation